Vietnam Radiotherapy Market Report 2022 to 2030

Vietnam Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Vietnam Radiotherapy Market will reach a value of $xx Mn from $35 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Vietnam is dominated by a few domestic players such as Viet Medical Equipment, Shimadzu Vietnam, and Varian Medical Systems. The radiotherapy market in Vietnam is segmented into different types, technology, procedures, application, and end-user. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Vietnam Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10VNPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Vietnam AUTHOR: Dr. Vishwa Modhia

Buy Now

Vietnam Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Vietnam Radiotherapy Market will reach a value of $xx Mn from $35 Mn in 2022, growing at a CAGR of xx% during 2022-30.

Vietnam, a low–middle-income Southeast Asian country with a population of 96.5 Mn, is the 15th most populous country in the world. The expected number of new cases in Vietnam in 2018 was 1,64,671 (0.17% of the population), with a total of 1,14,871 deaths (0.12% of the population). Both statistics have tripled in the last 30 years. Vietnam established the National Cancer Control Programme (NCCP) in 20029, implemented it in 20087, and reiterated its commitment to this programme in the national strategy for noncommunicable disease prevention and control in 2012. (NCDs).

From 2012 to 2015, the cancer control plan intends to enhance community awareness of cancer prevention and early detection, increase the number of early diagnosed cancer cases, and reduce mortality rates for breast, cervical, oral, and colorectal cancer. Vietnam's government spends 4.7% of its GDP on healthcare in 2020.

Vietnam Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

Along with surgery and chemotherapy, radiotherapy is one of the primary cancer treatment modalities in Vietnam. In Vietnam, the government is mandated to put aside 30% of the annual health budget for preventative medicine, with the remaining 70% allocated to tertiary care. Cancer care in Vietnam has improved significantly in recent years as a result of such a massive investment, with the number of radiotherapy units and oncology departments continuously expanding across the country. In terms of technology, the EBRT category accounted for the biggest revenue share of 88.2% in the radiation oncology market in 2019. These aspects could boost Vietnam Radiotherapy Market.

Market restrains.

In Vietnam, radiotherapy resources were scarce and unevenly dispersed, with the majority centred in Hanoi. Most departments lacked simulators or treatment planning systems, and they faced issues such as a shortage of skilled employees, equipment maintenance, and quality assurance. The national cancer registry data utilised as input to generate the aforementioned figures is of poor quality. There are few national statistics on cancer survivorship and mortality, for example. Existing hurdles include high smoking rates, a lack of cancer screening programmes, restricted access to optimum therapy, and reimbursement limits. These factors may deter new entrants into the Vietnam Radiotherapy Market.

Competitive Landscape

Key Players

Viet Medical Equipment JSC - Viet Medical Equipment is a leading domestic supplier of medical equipment, including radiotherapy equipment. The company offers a range of products, including linear accelerators, brachytherapy systems, and radiation protection solutions
Shimadzu Vietnam- Shimadzu is a Japanese company that provides a range of medical equipment, including radiotherapy equipment. The company has a presence in Vietnam and provides equipment to several healthcare facilities
Elekta - Elekta is a global company that provides advanced radiation therapy equipment and software solutions. In Vietnam, the company has a strong presence and offers a range of products, including linear accelerators, brachytherapy systems, and treatment-planning software
Varian Medical Systems - Varian is a leading manufacturer of radiotherapy equipment, including linear accelerators, brachytherapy systems, and software solutions. The company has a presence in Vietnam and provides equipment to several healthcare facilities
Accuray - Accuray is a global company that provides advanced radiation therapy equipment, including the CyberKnife system. The company has a presence in Vietnam and provides equipment to several healthcare facilities

Notable Recent Deals

March 2022: Roche Pharma Vietnam and the HCM City Cancer Hospital have agreed to strengthen collaboration with domestic and foreign oncology organisations and specialists, as well as to improve the professional skills of the hospital's medical professionals. The Memorandum of Understanding intends to increase diagnostic and therapeutic capacity, treatment, and patient support while also exchanging expertise across international organisations, implementing critical projects on breast, lung, and liver cancer, and building a patient treatment and care database.

Healthcare Policies and Reimbursement Scenarios

In Vietnam, the regulations and reimbursement of radiotherapy are overseen by the Ministry of Health (MOH) and the Vietnam Social Security (VSS). The MOH is responsible for regulating the use of radiation in Vietnam, including the use of radiotherapy. The Vietnam Society of Radiation Oncology (VSRO) is the main professional organization for radiation oncologists in Vietnam. The VSS is responsible for reimbursing the cost of radiotherapy for eligible patients under the national health insurance program.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.